mesowatch
HomeTalc Unit Fights for $8.9 Billion Bankruptcy Settlement
divider

Talc Unit Fights for $8.9 Billion Bankruptcy Settlement

chapter 11

Johnson & Johnson’s talc business LTL Management LLC fights its second Chapter 11 filing against the objections of talc injury plaintiffs. LTL Management’s objection filed with New Jersey bankruptcy court states it will offer claimants a landmark $8.9 billion settlement in the largest mass tort bankruptcy ever.

Unprecedented Commitment Amid Opposition

The objection makes the stark distinction between the filing today and the prior Chapter 11 case dismissed. LTL Management is very pleased with the settlement commitment it received from its parent J&J, now more than four times the previous commitment. That promise, the debtor argues, is unprecedented in favor of talc-claims resolution.

While most plaintiffs’ firms are in favor of the plan, a minority of talc claimants’ law firms object. LTL Management denounces this “vocal minority” for trying to stop the bankruptcy, and accuses them of having more money for themselves than for their clients.

This messy legal drama takes place as tens of thousands of people are making claims against J&J for the contamination of their talc with asbestos. But the talc claimants continue to insist that the products are safe, despite J&J’s statements about the safety of the products, and they challenge the legitimacy of LTL Management’s bankruptcy petitions.

During this battle, LTL Management hasn’t given up its battle for Chapter 11 protection and the $8.9 billion settlement offer. It will certainly be the court’s future ruling that will decide the course of one of the biggest mass tort bankruptcy trials ever.

Between law, politics and acrimony, the future of J&J’s talc business is at stake, billions of dollars on the line, and talc injury claimants’ justice on the front lines.

Michael McGrady

Reading Time: 1 mins

Published On: June 6, 2023

Michael McGrady - author

Michael McGrady is a critically acclaimed journalist based in the U.S. state of Colorado. He has an extensive background covering harm reduction and risk minimization topics within the realm of public health. You can find McGrady’s writing in outlets like Filter Magazine, Inside Sources, The South China Morning Post, and several others across the globe.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer